Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool (Q57542870)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

based on heuristic

inferred from title

Georgia Salanti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Georgia Salanti

1

0 references

publication date

11 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Research Synthesis Methods

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

80-97

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Commentary: evidence synthesis and evidence consistency

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Network meta-analysis with competing risk outcomes

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Making the best use of available evidence: the case of new generation antidepressants: A response to: Are all antidepressants equal?

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Study designs to detect sponsorship and other biases in systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Optimism bias leads to inconclusive results-an empirical study

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Indirect comparisons: a review of reporting and methodological quality

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Indirect comparisons of treatments based on systematic reviews of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Why we need a broad perspective on meta-analysis. It may be crucially important for patients

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Data extraction errors in meta-analyses that use standardized mean differences

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Systematic reviews of the effectiveness of quality improvement strategies and programmes

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Controlling the risk of spurious findings from meta-regression.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Systematic review data extraction: cross-sectional study showed that experience did not increase accuracy

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Indirect comparisons: the mesh and mess of clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Network meta-analysis of survival data with fractional polynomials

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Modeling between-trial variance structure in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Meta-analysis of mixed treatment comparisons at multiple follow-up times.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

A practical introduction to multivariate meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Estimating the power of indirect comparisons: a simulation study

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Adjusting for publication biases across similar interventions performed well when compared with gold standard data

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Bariatric surgery: a systematic review and network meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Relative citation impact of various study designs in the health sciences

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Parameterization of treatment effects for meta-analysis in multi-state Markov models.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Exploring the geometry of treatment networks.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Evaluation of new treatments in radiation oncology: are they better than standard treatments?

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Bayesian measures of model complexity and fit

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Use of indirect and mixed treatment comparisons for technology assessment

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Recent developments in meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJRSM.1037

21 January 2018

Identifiers

10.1002/JRSM.1037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26062083%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57542870&oldid=1500305567"